Benzinga | Jul 28, 2021 06:24AM EDT

Israel Chemicals Q2 EPS $0.11 Beats $0.09 Estimate, Sales $1.62B Beat $1.35B Estimate

Israel Chemicals (NYSE:ICL) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. This is a 83.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $1.62 billion which beat the analyst consensus estimate of $1.35 billion by 19.78 percent. This is a 34.41 percent increase over sales of $1.20 billion the same period last year.